The Effect of Alcohol on ABCA1 Expression and Lipid Metabolism

This study has been terminated.

( It was found that 20g of alcohol daily had no effect on ABCA1 expression or HDL levels. )

First Received on November 14, 2007. Last Updated on May 9, 2011 History of Changes

Sponsor:	Bayside Health
Information provided by:	Bayside Health
ClinicalTrials.gov Identifier:	NCT00558935

Purpose

The purpose of this study is to investigate the effects of red wine on ABCA1 levels

Condition	Intervention
Type 2 Diabetes Heart Disease	Dietary Supplement: Red Wine

Study Type:	Interventional
Study Design:	Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Caregiver, Investigator) Primary Purpose: Prevention

Resource links provided by NLM:

MedlinePlus related topics: Diabetes Diabetes Type 2 Heart Diseases

U.S. FDA Resources

Further study details as provided by Bayside Health:

Primary Outcome Measures:

Secondary Outcome Measures:

Estimated Enrollment:	20
Study Start Date:	October 2007
Study Completion Date:	December 2008
Primary Completion Date:	October 2008 (Final data collection date for primary outcome measure)

Intervention Details:

20g alcohol daily/red wine for 4 weeks

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00558935

Locations

Australia, Victoria
Baker Heart Research Institute
Melbourne, Victoria, Australia, 3004

Sponsors and Collaborators

Bayside Health

Investigators

Principal Investigator:

Bronwyn A Kingwell, PhD

Baker Heart Research Institute

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00558935 History of Changes
Other Study ID Numbers:	24/06
Study First Received:	November 14, 2007
Last Updated:	May 9, 2011
Health Authority:	Australia: Human Research Ethics Committee

Additional relevant MeSH terms:

Diabetes Mellitus, Type 2
Heart Diseases
Diabetes Mellitus
Glucose Metabolism Disorders

Metabolic Diseases
Endocrine System Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on February 09, 2012